389 results on '"Zhu, Wengen"'
Search Results
2. Comprehensive profiles of sulfur cycling microbial communities along a mangrove sediment depth
3. Lactate and lactylation in cardiovascular diseases: current progress and future perspectives
4. Real-world evidence of early rhythm control in patients with atrial fibrillation: A systematic review and meta-analysis
5. U-shaped association between the triglyceride–glucose index and atrial fibrillation incidence in a general population without known cardiovascular disease
6. Association between triglyceride glucose index and arterial stiffness and coronary artery calcification: a systematic review and exposure-effect meta-analysis
7. Association between epicardial adipose tissue and incident heart failure mediating by alteration of natriuretic peptide and myocardial strain
8. Association between weight loss and outcomes in patients undergoing atrial fibrillation ablation: a systematic review and dose–response meta-analysis
9. Association of hypertension burden with stroke risk in patients with heart failure with preserved ejection fraction
10. Circulating copper levels and the risk of cardio-cerebrovascular diseases and cardiovascular and all-cause mortality: A systematic review and meta-analysis of longitudinal studies
11. Association of the Triglyceride-Glucose Index With Risk of Alzheimer's Disease: A Prospective Cohort Study
12. Effect of edoxaban compared with other oral anticoagulants for stroke prevention in patients with atrial fibrillation: A meta-analysis
13. Depressive symptoms, anxiety and social stress are associated with diminished cardiovascular reactivity in a psychological treatment-naive population
14. Association of type 1 diabetes mellitus and risk of atrial fibrillation: Systematic review and meta-analysis
15. Effect of direct oral anticoagulants in patients with cerebral venous thrombosis
16. Worsening of Renal Function Among Hospitalized Patients With Acute Heart Failure: Phenotyping, Outcomes, and Predictors
17. Association of body mass index and prognosis in patients with HFpEF: A dose-response meta-analysis
18. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis
19. Effectiveness of early rhythm control in improving clinical outcomes in patients with atrial fibrillation: a systematic review and meta-analysis
20. Associations of BMI with mortality in HFpEF patients with concomitant diabetes with insulin versus non-insulin treatment
21. Effect of non-vitamin K oral anticoagulants for thrombosis prophylaxis in pediatric heart diseases
22. Performance of ChatGPT on the Chinese Postgraduate Examination for Clinical Medicine: Survey Study
23. Effect of Rivaroxaban or Apixaban in Atrial Fibrillation Patients with Stage 4–5 Chronic Kidney Disease or on Dialysis
24. S2I2N0–3 score predicts short‐ and long‐term mortality and morbidity in HFrEF: a post‐hoc analysis of the GUIDE‐IT trial.
25. Association of body mass index and all-cause mortality in patients after cardiac surgery: A dose-response meta-analysis
26. CHA2DS2-VASc and ATRIA Scores and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction
27. Non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: evidences from the real-world data
28. Comparison of factor X inhibitors versus vitamin K antagonists in atrial fibrillation patients on dialysis.
29. C2HEST score predicts clinical outcomes in heart failure with preserved ejection fraction: a secondary analysis of the TOPCAT trial
30. Host development overwhelms environmental dispersal in governing the ecological succession of zebrafish gut microbiota
31. Low vitamin D levels do not aggravate COVID-19 risk or death, and vitamin D supplementation does not improve outcomes in hospitalized patients with COVID-19: a meta-analysis and GRADE assessment of cohort studies and RCTs
32. Dose-response relationship of cardiorespiratory fitness with incident atrial fibrillation
33. Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease: A Meta-Analysis and Systematic Review
34. Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation Across BMI Categories: A Systematic Review and Meta-Analysis
35. Association of long-term SBP with clinical outcomes and quality of life in heart failure with preserved ejection fraction: an analysis of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial
36. Association of living alone with clinical outcomes in patients with heart failure: A systematic review and meta‐analysis.
37. Comparative Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients
38. O-GlcNAcylation of cardiac Nav1.5 contributes to the development of arrhythmias in diabetic hearts
39. Efficacy and Safety of the Use of Non-vitamin K Antagonist Oral Anticoagulants in Patients with Ischemic Heart Disease: A Meta-Analysis of Phase III Randomized Trials
40. Is There a Sex Difference in the Prognosis of Hypertrophic Cardiomyopathy? A Systematic Review and Meta‐Analysis
41. Editorial: Effects of oral anticoagulant therapy in atrial fibrillation patients with comorbidities
42. Performance of ChatGPT on Clinical Medicine Entrance Examination for Chinese Postgraduate in Chinese (Preprint)
43. Performance of ChatGPT on Clinical Medicine Entrance Examination for Chinese Postgraduate in Chinese
44. Meta-analysis of ATRIA versus CHA2DS2-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation
45. A simple ATTR‐CM score to identify transthyretin amyloid cardiomyopathy burden in HFpEF patients.
46. Effect of anticoagulation therapy in older patients with chronic kidney disease and atrial fibrillation: A meta-analysis
47. Relationship between smoking and adverse outcomes in patients with atrial fibrillation: A meta-analysis and systematic review
48. Can ventricular tachycardia non-inducibility after ablation predict reduced ventricular tachycardia recurrence and mortality in patients with non-ischemic cardiomyopathy? A meta-analysis of twenty-four observational studies
49. Author’s Reply to Vaz et al.: “Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease”
50. Comparison of liver fibrosis scores for predicting mortality and morbidity in heart failure with preserved ejection fraction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.